Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study
- PMID: 376137
Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study
Similar articles
-
Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.Recent Results Cancer Res. 1978;68:160-5. doi: 10.1007/978-3-642-81332-0_24. Recent Results Cancer Res. 1978. PMID: 752854 No abstract available.
-
Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.Cancer Treat Rep. 1979 Feb;63(2):297-9. Cancer Treat Rep. 1979. PMID: 376136 Clinical Trial. No abstract available.
-
Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1745-53. Cancer Treat Rep. 1979. PMID: 393378 Clinical Trial. No abstract available.
-
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347. Gynecol Oncol. 1994. PMID: 7835816 Review.
-
Clinical trials in ovarian carcinoma: study methodology.Ann Oncol. 2005;16 Suppl 8:viii20-viii29. doi: 10.1093/annonc/mdi963. Ann Oncol. 2005. PMID: 16239233 No abstract available.
Cited by
-
Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.J Natl Med Assoc. 1988 May;80(5):565-76. J Natl Med Assoc. 1988. PMID: 3047411 Free PMC article. Review.
-
Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder?Ann R Coll Surg Engl. 1981 Mar;63(2):118-25. Ann R Coll Surg Engl. 1981. PMID: 7247268 Free PMC article.
-
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.Cancer Immunol Immunother. 1988;27(3):246-54. doi: 10.1007/BF00205447. Cancer Immunol Immunother. 1988. PMID: 3180149 Free PMC article.
-
Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.Cancer Chemother Pharmacol. 1980;4(2):129-32. doi: 10.1007/BF00254034. Cancer Chemother Pharmacol. 1980. PMID: 7389058 Clinical Trial.